Company: GHRS
Filing Date: 2025-02-27
Form Type: 20-F
Source: 0001140361-25-006175
Chunk: 88

Company: GH Research PLC
Filing Date: 2025-02-27
Form: 20-F
Item: Item 6
Chunk 88
---

ITEM 6.   DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
----------------------------------------------------
A.
Directors and Senior Management
 
The following table presents information about our current executive officers and directors. The term of each of our directors is one year and, accordingly, will expire at our annual general meeting of shareholders to be held in 2025. Ages are as of December 31, 2024.

          Name                          Position(s)                     Age
---------------------------------------------------------------------------
Executive Officers                                                         
Velichka Valcheva         Chief Executive Officer                        50
Magnus Halle              Managing Director, Ireland                     28
Julie Ryan                Vice President, Finance                        39
Aaron Cameron             Chief Operating Officer                        40
Non-Executive Directors                                                    
Florian Schönharting      Chairman of the Board of Directors             56
Michael Forer             Vice Chairman of the Board of Directors        59
Dermot Hanley             Director                                       60
Duncan Moore              Director                                       65

 
 Unless otherwise indicated, the current business address for our executive officers and our non-executive directors is GH Research PLC, Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.
 

  Table of Contents
Executive Officers
 
Velichka (Villy) Valcheva, MD, MSc, has served as our Chief Executive Officer since September 2024. Prior to this, Dr. Valcheva served as our Chief Medical Officer since February 2024 and Vice President of Clinical Research and Medical Affairs since August 2023. Dr. Valcheva has more than 20 years of experience in various leadership roles in pharmaceutical and biotech industries. Dr. Valcheva served as VP and Head of Medical Affairs International for Albireo from 2020 until 2023, as well as Medical Lead/Monitor FIH study and clinical development from 2022. Prior to this, Dr. Valcheva served as Global Senior Medical Director Oncology - Hepatocellular Carcinoma for Ipsen from 2018 to 2020. Dr. Valcheva holds a Masters in Pharmaceutical Medicine from Trinity College Dublin, Ireland, as well as a Dr. Med. from University of Medicine – Plovdiv, Bulgaria.
Magnus Halle, has served as our Managing Director, Ireland since November 2020, is one of our co-founders, and served as a consultant to us from our founding in 2018 to 2020.